Evidence map›Paper›PMID 28586150›Full record

ArticleThe clinical respiratory journal2018

Analysis of viral infection and biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease.

Tiping Yin, Zhaoqin Zhu, Zhoufang Mei, Jingjing Feng, Wanju Zhang, Yanchao He, Jindong Shi, Ling Qian, Yi Liu, Qihui Huang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The clinical respiratory journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Tiping YinDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0002-9410-1827
Zhaoqin ZhuDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Shanghai, China.
Zhoufang MeiDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Jingjing FengDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Wanju ZhangDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Shanghai, China.
Yanchao HeDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Jindong ShiDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Ling QianDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Yi LiuDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Shanghai, China.
Qihui HuangDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Yunwen HuDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Shanghai, China.
Zhijun JieDepartment of Respiratory Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Fudan University · CNShanghai Public Health Clinical Center · CNWannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in Shanghai, and to analyze the clinical characteristics and biomarkers in viral infection.

methodsThis study included all consecutive patients who were admitted for a diagnosis of AECOPD during June 2013 to May 2015. Thirty-one stable COPD patients and 31 healthy controls were also recruited. Oropharyngeal samples were assessed, PCR for respiratory viruses were performed. Patients were divided into AECOPD virus-positive (+) group and AECOPD virus-negative (-) group according to viral detection. Luminex was used to detect the concentrations of inflammatory cytokines in the serum.

resultsA total of 264 patients were included with a mean age of 75 ± 0.5 years. There were 72 patients (27.3%) identified with viral positive, of whom two patients were detected with double viral infections (FluA + FluB and RSVA + HRV, respectively). The rate of viral detection was associated with season, highest in winter. Comparisons of clinical characteristics showed no significant differences between AECOPD virus+ group and AECOPD virus- group. However, serum concentrations of interferon-inducible protein-10 (IP-10) and interferon-gamma (IFN-γ) in virus+ AECOPD patients were significantly higher than those in the virus- AECOPD, stable COPD and healthy control groups (P < .05).

conclusionViral infection was an important pathogen in AECOPD patients; the most common viruses included FluA, HRV and FluB. It was very difficult to diagnose the viral infection according to clinical characteristics. The increased of serum IP-10 and IFN-γ levels might be value to indicate viral infection in AECOPD.

Indexed as

AgedBiomarkersChinaComorbidityCytokinesDisease ProgressionDNA, ViralFemaleHumansMalePolymerase Chain ReactionPrognosisPulmonary Disease, Chronic ObstructiveRecurrenceRetrospective StudiesSurvival RateBiomarkersCytokinesDNA, Viralacute exacerbation of chronic obstructive pulmonary diseasechronic obstructive pulmonary diseasecytokineIP-10viral infection

Identifiers

PMID28586150
PMCPMC7162408
OpenAlexW2621736196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.